STING fever is sweeping through the cancer immunotherapy world – Chemical & Engineering News
Chemical & Engineering News |
STING fever is sweeping through the cancer immunotherapy world
Chemical & Engineering News The crystal structure of human STING, with the agonist ADU-S100, currently in a Phase I clinical trial from Aduro Biotech and Novartis. Credit: Aduro Biotech/Christian Lee/Genomics Institute of the Novartis Research Foundation. When Archie Tse was a … |
